Novartis Financial Statements (NVS)

Wires

Forums

Community

Quotes

Stocks

Calendar

Information

Books

Analysis

Novartis shareholders
Novartis Financial Statements (NVS)
Years Quarters US GAAP
Novartissmart-lab.ru	%	2021	2021	2022	2022	2023	LTM ?
Report date		31.12.2021	02.02.2022	31.12.2022	01.02.2023	31.01.2024	31.03.2024
Currency		USD	USD	USD	USD	USD	USD
Financial report URL

Revenue, bln rub	?	52 877	52 877	51 828	51 828	46 660	49 633
Operating Income, bln rub		26 948	26 948	9 197	9 197	9 769	10 893
EBITDA, bln rub	?	33 061	33 061	16 389	16 389	18 469	18 828
Net profit, bln rub	?	24 021	24 021	6 955	6 955	14 850	15 245

OCF, bln rub	?	15 071	15 071	14 236	14 236	14 458	13 766
CAPEX, bln rub	?	2 971	2 971	2 671	2 671	2 753	3 618
FCF, bln rub	?	12 100	12 100	11 565	11 565	11 705	10 148
Dividend payout, bln rub		7 368	7 368	7 506	7 506	7 255	5 207

Ordinary share dividend yield, %		0.00%	0.00%	0.00%	0.00%	0.00%	0
Dividend payout ratio, %		30.7%	30.7%	107.9%	107.9%	48.9%	34.2%

OPEX, bln rub		25 321	25 321	27 145	27 145	24 419	25 130
Cost of production, bln rub		15 867	15 867	15 486	15 486	12 472	13 610
R&D, bln rub		9 540	9 540	9 996	9 996	11 371	11 248
Interest expenses, bln rub		811.0	811.0	837.0	837.0	855.0	884.0

Assets, bln rub		131 795	131 795	117 453	117 453	99 945	94 334
Net Assets, bln rub	?	67 655	67 655	59 342	59 342	46 667	39 675
Debt, bln rub		31 093	31 093	27 964	27 964	26 348	27 284
Cash, bln rub		28 329	28 329	18 930	18 930	13 962	9 694
Net debt, bln rub		2 764	2 764	9 034	9 034	12 386	17 590

Ordinary share price, rub		87.5	82.8	90.7	85.9	101.0	84.0
Number of ordinary shares, mln		2 243	2 243	2 181	2 181	2 077	2 044

Market cap, bln rub		196 195	185 620	197 860	187 254	209 694	171 696
EV, bln rub	?	198 959	188 384	206 894	196 288	222 080	189 286
Book value, bln rub		3 878	3 878	-1 603	-1 603	-3 553	-9 660

EPS, rub	?	10.7	10.7	3.19	3.19	7.15	7.46
FCF/share, rub		5.39	5.40	5.30	5.30	5.64	4.96
BV/share, rub		1.73	1.73	-0.73	-0.73	-1.71	-4.73

EBITDA margin, %	?	62.5%	62.5%	31.6%	31.6%	39.6%	37.9%
Net margin, %	?	45.4%	45.4%	13.4%	13.4%	31.8%	30.7%
FCF yield, %	?	6.17%	6.52%	5.85%	6.18%	5.58%	5.91%
ROE, %	?	35.5%	35.5%	11.7%	11.7%	31.8%	38.4%
ROA, %	?	18.2%	18.2%	5.92%	5.92%	14.9%	16.2%

P/E	?	8.17	7.73	28.4	26.9	14.1	11.3
P/FCF		16.2	15.3	17.1	16.2	17.9	16.9
P/S	?	3.71	3.51	3.82	3.61	4.49	3.46
P/BV	?	50.6	47.9	-123.4	-116.8	-59.0	-17.8
EV/EBITDA	?	6.02	5.70	12.6	12.0	12.0	10.1
Debt/EBITDA		0.08	0.08	0.55	0.55	0.67	0.93

R&D/CAPEX, %		321.1%	321.1%	374.2%	374.2%	413.0%	310.9%

CAPEX/Revenue, %		5.62%	5.62%	5.15%	5.15%	5.90%	7.29%

Have an idea?

Moscow Exchange is the source and the owner of marketdata. The users haven't right of further distribution or presentation of any data without written permission of Moscow Exchange, haven't right to create modified information for further public distribution to third parties.